Lyell Announces Presentation of Initial Clinical Data From the Phase 1-2 Clinical Trial of Impt-314 for the Treatment of B-Cell Lymphoma at the 2024 American Society of Hematology (Ash) Annual Meeting
Lyell宣佈在2024年美國血液學學會(Ash)年會上發佈Impt-314用於治療b-細胞淋巴瘤的1-2期臨床試驗初步數據報告
